HSBC overhauls European pharma ratings and flags AI rotation risk - Investing.com
HSBC overhauls European pharma ratings and flags AI rotation risk · Roche Holding was cut to “hold” from “buy,” with the target price left unchanged at ...
Read the original at Investing.com ↗
- Topics
- Healthcare
- Mentions
- Europe
- Tracked via
- “AI Risks”